Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 37Head and Neck Neoplasms 28Prostatic Neoplasms 16Oropharyngeal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Gliosarcoma 8Glioblastoma 8Carcinoma, Squamous Cell 7Brain Neoplasms 7Tongue Neoplasms 6Rectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Laryngeal Neoplasms 5Astrocytoma 5Papillomavirus Infections 4Neoplasm Metastasis 4Mouth Neoplasms 4Sarcoma 3Neoplasms 3Hypopharyngeal Neoplasms 3Glioma 3Carcinoma 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Stomatitis 2Rhabdomyosarcoma 2Radiation Injuries 2

Interventions

Radiosurgery 2encorafenib 1binimetinib 1alovudine 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Metastasectomy 1Leuprolide 1Goserelin 1Docetaxel 1DEAE-Dextran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphatic Metastasis × Radiotherapy, Intensity-Modulated × Clear all
NCT03796767 2026-01-28

SOAR

University of Utah

Phase 2 Active not recruiting
20 enrolled 26 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡